Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Linden Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Linden Advisors
from 13F filings
Historical chart of Linden Advisors investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Linden Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Linden Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $77B | 82M | 937.06 |
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1